HMGB1 and cancer: Thus, it is expected that papaverine-mimetic 3-styrylchromone derivatives, which possess both potent anti-inflammatory and anti-cancer activities targeting the HMGB1-RAGE axis, may become valuable leads for developing a new type of anti-cancer pharmaceutical.